Pancreatic cancer is the fourth leading cause of cancer-related death worldwide. Extensive research has yielded advances in first-line treatment strategies, but there is no standardized second-line therapy. In this review, we examine the literature trying to establish a possible therapeutic algorithm.
Keywords: Algorithm; Nab-paclitaxel; Nal-iri; Pancreatic cancer; Second line.